Abstract: In a transfer device and a process for discrete elements, fed in a line with a predetermined spacing, variations in the dimensions of the discrete elements resulting in a variation in a release spot included in a release segment, are absorbed by an alignment of the receiving elements. A transport device of the transfer device has receiving elements, each configured to receive a respective discrete element and moving along a transport path at a predetermined speed. The discrete elements are transported on a release device of the transfer device along a release path with a linear development. The release path has a release segment intersecting the transport path at a receiving segment of the transport path. The transport device includes a moving mechanism for the receiving elements to align the receiving elements at the receiving segment, where the release segment is superimposed on the transport path at the receiving segment.

Abstract: A coupling method for coupling a component of a container to the container is presented. The method includes: arranging a coupling unit including a coupling assembly with a frame, a gripping device for the component, a coupling device for constraining the component to the container; arranging the container and the component at least partially within the container, providing at least a minimum spacing between a bottom of the component and a base of the container; moving and activating the gripping device at a removal position of the component; moving the retaining element and the coupling element to a coupling position; deactivating the retaining element, thus deactivating a constraint between the gripping element and the component; and activating said coupling element to produce a stable coupling between the couplable portion of the component and the container, deactivating and moving the coupling element.

Abstract: It is described the use of L-carnitine and/or one or more alkanoyl L-carnitines, or mixture thereof, or one of their pharmaceutically acceptable salts, for the preparation of a medicament or a nutritional supplement useful for preventing or treating the Leber optic neuropathy.

Abstract: It is described the use of L-carnitine and/or one or more alkanoyl L-carnitines, or mixture thereof, or one of their pharmaceutically acceptable salts, for the preparation of a medicament or a nutritional supplement useful for preventing or treating the Leber optic neuropathy.

Abstract: It is described the use of a combination consisting of a microcapsule suspension comprising one or more statins in alkyl esters of n-3 PUFA in which the statins are isolated from contact with the alkyl ester of n-3 PUFA by means of a polymeric membrane that can be easily disintegrated in the gastrointestinal medium, for the treatment of cardiovascular diseases.

Abstract: The present invention relates to the use of acetyl L-carnitine for the preparation of a medicament for the prevention and/or treatment of cancer. Methods of preventing and/or treatment of cancer by administering an effective amount of acetyl L-carnitine to subject in need thereof are also disclosed.